Stocktoria
NewcelX Ltd. NCEL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-01-29
NewcelX Ltd. statistics & valuation
Market cap$19.5M
P / B2.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -72.5% | -797.0% | -180.4% | -177.8% | -207.2% |
| Return on equity | -114.5% | 90.0% | 278.4% | -14861.0% | -2202.5% |
| Current ratio | 0.76 | 0.09 | 0.23 | 2.75 | 2.38 |
Source: SEC EDGAR filings · CIK 0001783036 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.